发明名称 |
Process for the preparation of aliskiren |
摘要 |
The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as Aliskiren, or a salt thereof, preferably Aliskiren hemifumarate. |
申请公布号 |
US9056816(B2) |
申请公布日期 |
2015.06.16 |
申请号 |
US201214354524 |
申请日期 |
2012.10.19 |
申请人 |
JUBILANT LIFE SCIENCES LIMITED |
发明人 |
Biswas Sujay;Srimurugan Sankareswaran;Kumar Anjul;Panda Atulya Kumar;Jamshad Danish;Masand Mukesh;Biswas Bidyut;Bansal Vikas;Gupta Ashish Kumar;Vir Dharam |
分类号 |
C07C231/10;C07C231/02;C07D307/33;C07D307/20 |
主分类号 |
C07C231/10 |
代理机构 |
Knobbe, Martens, Olsen & Bear, LLP |
代理人 |
Knobbe, Martens, Olsen & Bear, LLP |
主权项 |
1. A process for the preparation of Aliskiren hemifumarate of Formula I, comprising the steps of: (i) reducing the compound of Formula VIIA with or without isolation of intermediate of Formula VIIA-Int, to obtain the compound of Formula VIIA-amine, which can be optionally converted to acid-addition salt thereof; (ii) protecting the compound of Formula VITA-amine with a suitable protecting agent in the presence of a base to obtain the compound of Formula VIIA-N-PG, wherein PG is a protecting group selected from the group consisting of BOC, FMOC, substituted or unsubstituted Cbz and trityl; (iii) reacting the compound of Formula VITA-N-PG with compound of Formula C in presence of 2-hydroxy pyridine and base to obtain compound of the Formula X—N-PG wherein PG is a protecting group selected from the group consisting of BOC, FMOC, substituted or unsubstituted Cbz and trityl; (iv) deprotecting the compound of Formula X—N-PG with acid or base or catalytic hydrogenolysis using hydrogen gas or catalytic hydrogen transfer in presence of organic solvent to obtain Aliskiren of the Formula X (v) treating Aliskiren of the Formula X with fumaric acid to obtain Aliskiren hemifumarate of Formula I. |
地址 |
Noida, Uttar Pradesh IN |